273 related articles for article (PubMed ID: 32100878)
1. Intraductal papillary neoplasms of the bile duct consist of two distinct types specifically associated with clinicopathological features and molecular phenotypes.
Aoki Y; Mizuma M; Hata T; Aoki T; Omori Y; Ono Y; Mizukami Y; Unno M; Furukawa T
J Pathol; 2020 May; 251(1):38-48. PubMed ID: 32100878
[TBL] [Abstract][Full Text] [Related]
2. Targeted next-generation sequencing identifies distinct clinicopathologic and molecular entities of intraductal papillary neoplasms of the bile duct.
Yang CY; Huang WJ; Tsai JH; Cheng A; Chen CC; Hsu HP; Jeng YM
Mod Pathol; 2019 Nov; 32(11):1637-1645. PubMed ID: 31231124
[TBL] [Abstract][Full Text] [Related]
3. GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct.
Sasaki M; Matsubara T; Nitta T; Sato Y; Nakanuma Y
PLoS One; 2013; 8(12):e81706. PubMed ID: 24312577
[TBL] [Abstract][Full Text] [Related]
4. Comparative clinicopathological study of biliary intraductal papillary neoplasms and papillary cholangiocarcinomas.
Fujikura K; Fukumoto T; Ajiki T; Otani K; Kanzawa M; Akita M; Kido M; Ku Y; Itoh T; Zen Y
Histopathology; 2016 Dec; 69(6):950-961. PubMed ID: 27410028
[TBL] [Abstract][Full Text] [Related]
5. Intraductal Papillary Neoplasm of Bile Duct: Updated Clinicopathological Characteristics and Molecular and Genetic Alterations.
Nakanuma Y; Uesaka K; Kakuda Y; Sugino T; Kubota K; Furukawa T; Fukumura Y; Isayama H; Terada T
J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33317146
[TBL] [Abstract][Full Text] [Related]
6. RNF43 mutation frequently occurs with GNAS mutation and mucin hypersecretion in intraductal papillary neoplasms of the bile duct.
Tsai JH; Liau JY; Yuan CT; Cheng ML; Yuan RH; Jeng YM
Histopathology; 2017 Apr; 70(5):756-765. PubMed ID: 27864998
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological characterization of so-called "cholangiocarcinoma with intraductal papillary growth" with respect to "intraductal papillary neoplasm of bile duct (IPNB)".
Nakanuma Y; Sato Y; Ojima H; Kanai Y; Aishima S; Yamamoto M; Ariizumi S; Furukawa T; Hayashi H; Unno M; Ohta T;
Int J Clin Exp Pathol; 2014; 7(6):3112-22. PubMed ID: 25031730
[TBL] [Abstract][Full Text] [Related]
8. Biliary intraductal tubule-forming neoplasm: a whole exome sequencing study of MUC5AC-positive and -negative cases.
Akita M; Hong SM; Sung YN; Kim MJ; Ajiki T; Fukumoto T; Itoh T; Zen Y
Histopathology; 2020 Jun; 76(7):1005-1012. PubMed ID: 32181510
[TBL] [Abstract][Full Text] [Related]
9. KRAS mutation and immunohistochemical profile in intraductal papillary neoplasm of the intrahepatic bile ducts.
Xian ZH; Qin C; Cong WM
Pathol Res Pract; 2018 Jan; 214(1):105-111. PubMed ID: 29103773
[TBL] [Abstract][Full Text] [Related]
10. Recurrent Mutations in APC and CTNNB1 and Activated Wnt/β-catenin Signaling in Intraductal Papillary Neoplasms of the Bile Duct: A Whole Exome Sequencing Study.
Fujikura K; Akita M; Ajiki T; Fukumoto T; Itoh T; Zen Y
Am J Surg Pathol; 2018 Dec; 42(12):1674-1685. PubMed ID: 30212390
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Intraductal Papillary Neoplasm of the Bile Duct with Respect to the Histopathologic Similarities to Pancreatic Intraductal Papillary Mucinous Neoplasm.
Nakanuma Y; Kakuda Y; Uesaka K
Gut Liver; 2019 Nov; 13(6):617-627. PubMed ID: 30982236
[TBL] [Abstract][Full Text] [Related]
12. The Pathologic and Genetic Characteristics of the Intestinal Subtype of Intraductal Papillary Neoplasms of the Bile Duct.
Nakanuma Y; Kakuda Y; Fukumura Y; Sugino T; Uesaka K; Serizawa M; Terada T; Ohnishi Y
Am J Surg Pathol; 2019 Sep; 43(9):1212-1220. PubMed ID: 31166202
[TBL] [Abstract][Full Text] [Related]
13. A statement by the Japan-Korea expert pathologists for future clinicopathological and molecular analyses toward consensus building of intraductal papillary neoplasm of the bile duct through several opinions at the present stage.
Nakanuma Y; Jang KT; Fukushima N; Furukawa T; Hong SM; Kim H; Lee KB; Zen Y; Jang JY; Kubota K
J Hepatobiliary Pancreat Sci; 2018 Mar; 25(3):181-187. PubMed ID: 29272078
[TBL] [Abstract][Full Text] [Related]
14. Reappraisal of pathological features of intraductal papillary neoplasm of bile duct with respect to the type 1 and 2 subclassifications.
Nakanuma Y; Uesaka K; Okamura Y; Terada T; Fukumura Y; Kakuda Y; Sugino T; Sato Y; Taek JK; Park YN
Hum Pathol; 2021 May; 111():21-35. PubMed ID: 33508254
[TBL] [Abstract][Full Text] [Related]
15. GNAS codon 201 mutations are uncommon in intraductal papillary neoplasms of the bile duct.
Matthaei H; Wu J; Dal Molin M; Debeljak M; Lingohr P; Katabi N; Klimstra DS; Adsay NV; Eshleman JR; Schulick RD; Kinzler KW; Vogelstein B; Hruban RH; Maitra A
HPB (Oxford); 2012 Oct; 14(10):677-83. PubMed ID: 22954004
[TBL] [Abstract][Full Text] [Related]
16. Development of intraductal papillary neoplasm of the bile duct in patients with occupational cholangiocarcinoma.
Kubo S; Tanaka S; Kinoshita M; Shinkawa H; Ishizawa T; Sato Y
Virchows Arch; 2023 Apr; 482(4):745-753. PubMed ID: 36715769
[TBL] [Abstract][Full Text] [Related]
17. Impact of Tumor Location on Postoperative Outcome of Intraductal Papillary Neoplasm of the Bile Duct.
Matsumoto T; Kubota K; Hachiya H; Sakuraoka Y; Shiraki T; Shimizu T; Mori S; Iso Y; Kato M; Yamagishi H; Imai Y; Aoki T
World J Surg; 2019 May; 43(5):1313-1322. PubMed ID: 30659344
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features and prognosis of mucin-producing bile duct tumor and mucinous cystic tumor of the liver: a multi-institutional study by the Japan Biliary Association.
Kubota K; Nakanuma Y; Kondo F; Hachiya H; Miyazaki M; Nagino M; Yamamoto M; Isayama H; Tabata M; Kinoshita H; Kamisawa T; Inui K
J Hepatobiliary Pancreat Sci; 2014 Mar; 21(3):176-85. PubMed ID: 23908126
[TBL] [Abstract][Full Text] [Related]
19. CT imaging comparison between intraductal papillary neoplasms of the bile duct and papillary cholangiocarcinomas.
Komori T; Inoue D; Zen Y; Yoneda N; Kitao A; Kozaka K; Yokka A; Toshima F; Matsubara T; Kobayashi S; Gabata T
Eur Radiol; 2019 Jun; 29(6):3132-3140. PubMed ID: 30519930
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological characteristics of intraductal papillary neoplasm of the bile duct: a Japan-Korea collaborative study.
Kubota K; Jang JY; Nakanuma Y; Jang KT; Haruyama Y; Fukushima N; Furukawa T; Hong SM; Sakuraoka Y; Kim H; Matsumoto T; Lee KB; Zen Y; Kim J; Miyazaki M; Choi DW; Heo JS; Endo I; Hwang S; Nakamura M; Han HS; Uemoto S; Park SJ; Hong EK; Nanashima A; Kim DS; Kim JY; Ohta T; Kang KJ; Fukumoto T; Nah YW; Seo HI; Inui K; Yoon DS; Unno M
J Hepatobiliary Pancreat Sci; 2020 Sep; 27(9):581-597. PubMed ID: 32511838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]